The suppression of Tie2 signaling caused by the use of specific blocking agents may be able to suppress the growth of tumors and several studies have shown that interfering with the Tie2 receptor pathway resulted in the inhibition of tumor angiogenesis and growth (24–27). Here, TEK is linked to neoplasm.